Cann Group Limited
CNGGFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1060031
P/E Ratio—
52W High$0.0278
52W Low$0.0015
Cann Group Limited (CNGGF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CNGGF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 27, 2026EPS Actual
$0.02
Revenue
$0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 27, 2026
After Market Close
CNGGF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 28, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 24, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 27, 2026 | — | $0.02 | — | $0.00B | — | — |
| — Q3 FY2025 | Sep 1, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2025 | Feb 26, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Oct 22, 2024 | — | -$0.06 | — | $0.01B | — | — |
| — Q2 FY2024 | May 8, 2024 | — | -$0.02 | — | $0.01B | — | — |
| ▼ Q4 FY2022 | Dec 31, 2022 | -$0.03 | -$0.04 | -6.1% | $0.00B | $0.01B | -27.5% |
Q3 FY2026
Aug 28, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 27, 2026
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Sep 1, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 26, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Oct 22, 2024
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
May 8, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
-$0.04
EPS Est.
-$0.03
EPS Surpr.
-6.1%
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 27, 2026 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2025 | Sep 1, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q1 FY2025 | Feb 26, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2024 | Oct 22, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q2 FY2024 | May 8, 2024 | — | $0.03 | $0.03 | +7.14% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -6.1% | $0.14 | $0.14 | -0.17% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.20 | $0.20 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.20 | $0.21 | +6.57% |
Q1 FY2026+0.00%
Report Date
Feb 27, 2026
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2025+0.00%
Report Date
Sep 1, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2025+0.00%
Report Date
Feb 26, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2024+0.00%
Report Date
Oct 22, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024+7.14%
Report Date
May 8, 2024
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q4 FY2022-0.17%
Report Date
Dec 31, 2022
EPS Beat/Miss
-6.1%
Price Before
$0.14
Price After
$0.14
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q4 FY2021+6.57%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.21
Avg Miss Reaction-0.17%
Beat Rate0 / 8 quarters
Largest Move+7.14% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CNGGF ends December
Cann Group Limited (CNGGF) most recently reported earnings on February 27, 2026 for Q1 FY2026, posting EPS of $0.02 (in line with the analyst consensus of —). The next CNGGF earnings date is expected around September 1, 2026.
Each quarter, investors track CNGGF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CNGGF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CNGGF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CNGGF earnings · 4 questionsCann Group Limited's next earnings report is expected around September 1, 2026. CNGGF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CNGGF historically reports after market close (AMC).
CNGGF earnings datewhen is CNGGF earningsCNGGF next earnings datewhen does CNGGF report earningsCNGGF earnings calendar
▸ Source: FMP · Cann Group Limited SEC filings · US GAAP · Cann Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026